| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 09/21/2000 | CA2367354A1 6-substituted biaryl purine derivatives as potent cyclin/cdk inhibitors and antiproliferative agents |
| 09/21/2000 | CA2367340A1 Substituted 2-aminobenzamide caspase inhibitors and the use thereof |
| 09/21/2000 | CA2366838A1 A method of treating bulimia nervosa and related eating disorders by administration of atypical antipsychotic medications |
| 09/21/2000 | CA2366195A1 Human pancreas and pancreatic cancer associated gene sequences and polypeptides |
| 09/21/2000 | CA2366174A1 Human colon cancer associated gene sequences and polypeptides |
| 09/21/2000 | CA2366130A1 Human cancer associated gene sequences and polypeptides |
| 09/21/2000 | CA2365655A1 Retrovirus producting cells utilizing a high multiplicity of transduction |
| 09/21/2000 | CA2365214A1 Vertebrate protein slit, dna sequence encoding it and uses thereof |
| 09/21/2000 | CA2364739A1 Regulators of intracellular phosphorylation |
| 09/21/2000 | CA2364637A1 50 human secreted proteins |
| 09/21/2000 | CA2364635A1 47 human secreted proteins |
| 09/21/2000 | CA2364629A1 Human lung cancer associated gene sequences and polypeptides |
| 09/21/2000 | CA2364590A1 Human prostate cancer associated gene sequences and polypeptides |
| 09/21/2000 | CA2364549A1 50 human secreted proteins |
| 09/21/2000 | CA2363705A1 Devices and methods for pain management |
| 09/21/2000 | CA2363496A1 Differential expression of organellar gene products |
| 09/21/2000 | CA2363022A1 49 human secreted proteins |
| 09/21/2000 | CA2361939A1 Modified amino acid amides, pharmaceutical compositions containing these compounds and processes for preparing them |
| 09/21/2000 | CA2361819A1 Amide derivatives |
| 09/21/2000 | CA2361289A1 Compositions for promoting nerve regeneration |
| 09/21/2000 | CA2332767A1 Dhea composition and method |
| 09/20/2000 | EP1036794A1 2-aryl-8-oxodihydropurine derivatives, process for producing the same, medicinal compositions containing the same, and intermediates thereof |
| 09/20/2000 | EP1036191A2 Method for identifying ihbitors of g-protein coupled receptor hibef51 |
| 09/20/2000 | EP1036175A1 Human brain derived kcnq2 potassium channel |
| 09/20/2000 | EP1036092A2 Hydrophobically-modified protein compositions and methods |
| 09/20/2000 | EP1036069A1 Benzenesulfonamide compounds |
| 09/20/2000 | EP1036065A1 Substituted imidazole derivatives having agonist-like activity at alpha 2b or 2b/2c adrenergic receptors |
| 09/20/2000 | EP1035858A1 Use of ginkgo biloba extracts for preparing a medicine |
| 09/20/2000 | EP1035856A1 Isolated dna encoding human h3 histamine receptor |
| 09/20/2000 | EP1035845A1 Modulators of cysteine protease |
| 09/20/2000 | EP1035843A2 I h?-MODULATORS |
| 09/20/2000 | EP1035833A1 Compositions for nasal administration |
| 09/20/2000 | EP1035824A1 A process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs |
| 09/20/2000 | EP0874805B1 Phenylacetamide derivatives |
| 09/20/2000 | EP0734376B1 Vitamin d amine and amide derivatives |
| 09/20/2000 | EP0696288B1 Quinoxalindione derivatives, their preparation and their use in drugs |
| 09/20/2000 | CN1267303A 3-substd. 3,4,5,7-tetrahydro-pyrrolo [3',4' : 4,5] thieno [2,3-d] pyrimidine derivs, their preparation and use as 5HT antagonists |
| 09/20/2000 | CN1267286A 2-{3-[4-(2-t-butyl-6-trifluoromethylpyridin-4-yl) piperazin-1-yl] propylmercapto} pyrimidin-4-ol-fumarate |
| 09/20/2000 | CN1267225A Method for treatment of patients afflicted with multiple sclerosis using consensus interferon |
| 09/20/2000 | CN1267219A Compositions, kits, and methods for inhibiting cerebral neurovascular disorders and muscular headaches |
| 09/20/2000 | CN1267218A Use of phanquinone for treatment of alzheimer's disease |
| 09/20/2000 | CN1267215A Pharmacetical compositions contg. effervescent acid-base couple |
| 09/20/2000 | CN1266702A Antidepressive capsule and preparing process thereof |
| 09/20/2000 | CN1266685A Process for preparing long-acting compound analgesic |
| 09/20/2000 | CN1056615C Difluoro pentapeptide deriv. antiinflammatory agent |
| 09/20/2000 | CN1056611C Pyrazolo and pyrrolopyridines, their use and intermidiates for preparing same |
| 09/20/2000 | CN1056610C Piperidine or piperazine derivs, pharmaceutical compositions contg. them and their use |
| 09/20/2000 | CN1056607C Tricyclic pyrazole derivs. |
| 09/20/2000 | CN1056606C Substd. dihydro-pyridine dicarboxylate, its preparing method, medicine contg. same and use thereof |
| 09/20/2000 | CN1056605C Compounds as selective human NK 3-receptor antagonists and their use |
| 09/19/2000 | US6121459 Reacting aryl-substituted-propargylhydroxylamine with azabicycloketone; oximination |
| 09/19/2000 | US6121416 Peptide which prevents the binding of somatomedins and their binding proteins; for the treatment of hyperglycemic, obesity, nervous system, cardiovascular, kidney, immunological and metabolic disorders |
| 09/19/2000 | US6121375 Gels formed by the interaction of poly(aldehyde) with various substances |
| 09/19/2000 | US6121326 Antiinflammatory agents; antiallergens; analgesics; antiemetics |
| 09/19/2000 | US6121306 Resolving racemic mixture into (1s,4r)- and (1r,4s)-1-azabicyclo(2.2.1)heptan-3-one isomers by formation of di-p-toluoyl hemitartrate salts; storage stable form; use to prepare drugs such as muscarinic agonists |
| 09/19/2000 | US6121291 Paroxetine in the treatment of depression associated with withdrawal from heroin abuse and post-traumatic stress disorder |
| 09/19/2000 | US6121284 Specified 1-(alkyl or cycloalkyl)-2-methyl-3-(alkoxycarbonyl)-4-(substituted pyridyl or aryl)-5-oxo-1,4,5,6,7,8-hexahydroquinoline compounds; treating sickle cell anemia, psychoses, depression |
| 09/19/2000 | US6121280 Azabicyclic rotomase inhibitors |
| 09/19/2000 | US6121279 Phosphodiesterase inhibitor for treating respiratory system disorders |
| 09/19/2000 | US6121274 Phosphodiesterase inhibitor for treatment of respiratory system disorders |
| 09/19/2000 | US6121265 Excitatory amino acid receptor antagonists |
| 09/19/2000 | US6121259 Olanzapine-N-oxide compositions and methods |
| 09/19/2000 | US6121252 N-acetylated alpha-linked acidic dipeptidase (naaladase) enzyme inhibitors to treat glutamate abnormalities and prostate diseases |
| 09/19/2000 | US6121231 Use of the KAL protein and treatment with the KAL protein in treatment of retinal, renal, neuromal and neural injury |
| 09/19/2000 | US6121046 Synthetic antisense oligodeoxynucleotides targeted to human ache |
| 09/19/2000 | US6121018 Polynucleotide which codes for polypeptide of defined amino acid sequence; for therapy and diagnosis of alzheimer's/ parkinson's diseases, multiple sclerosis, amyotrophic lateral sclerosis, septic shock, osteoporosis and other diseases |
| 09/19/2000 | CA2141679C New derivatives of neuraminic acid |
| 09/19/2000 | CA2107484C New arylalkyl(thio)amides, their preparation process and pharmaceutical compositions containing them |
| 09/19/2000 | CA2106768C Bradykinin type peptides |
| 09/19/2000 | CA2018563C N-heteroaryl-purin-6-amines, a process for their preparation and their use as medicaments |
| 09/15/2000 | CA2301679A1 Medication for treatment of functional distrubances or illnesses of the lower intestinal tract, particularly abdominal visceral pain which accompanies them |
| 09/14/2000 | WO2000053742A2 Polynucleotides and proteins encoded thereby |
| 09/14/2000 | WO2000053738A2 Methods and compositions for regulating memory consolidation |
| 09/14/2000 | WO2000053733A2 Hermansky pudlak syndrome protein-interacting proteins and methods of use thereof |
| 09/14/2000 | WO2000053628A2 Genes encoding human potassium channel proteins |
| 09/14/2000 | WO2000053608A1 Pyridopyranoazepine derivatives, preparation and therapeutic use |
| 09/14/2000 | WO2000053604A1 Carbamoyl tetrahydropyridine derivatives |
| 09/14/2000 | WO2000053602A1 6-azaindole compounds as antagonists of gonadotropin releasing hormone |
| 09/14/2000 | WO2000053596A2 Imidazole compounds as histamine h3 ligands |
| 09/14/2000 | WO2000053582A1 HETEROCYCLIC COMPOUNDS HAVING EFFECT OF ACTIVATING NICOTINIC ACETYLCHOLINE α4β2 RECEPTOR |
| 09/14/2000 | WO2000053572A1 Biphenyl derivatives as antagonists of the neurokinine-1 receptor |
| 09/14/2000 | WO2000053547A1 Method of preparing surface-active alcohols and surface-active alcoholic ethers, products obtained by said method and their use |
| 09/14/2000 | WO2000053233A1 Use of protein conformation for the protection and release of chemical compounds |
| 09/14/2000 | WO2000053218A1 Neurodegenerative disorder related gene |
| 09/14/2000 | WO2000053217A2 Prevention of fetal alcohol syndrome and neuronal cell death with adnf polypeptides |
| 09/14/2000 | WO2000053192A1 Use of xenon for treating neurointoxications |
| 09/14/2000 | WO2000053182A2 3-cyclopropylmethoxy-4-difluoromethoxy-n-(3,5-dichloropyrid-4-yl)benzamide in the treatment of multiple sclerosis |
| 09/14/2000 | WO2000053178A1 6-azaindole compounds as antagonists of gonadotropin releasing hormone |
| 09/14/2000 | WO2000053019A1 Dna vaccination for treatment of autoimmune disease |
| 09/14/2000 | WO2000037685A3 Method of identifying a psychotropic agent using differential gene expression |
| 09/14/2000 | WO2000037422A3 Ion channel modulating agents |
| 09/14/2000 | WO2000035430A3 Homer a new target of treating psychiatric disorders |
| 09/14/2000 | WO2000031263A3 Gtpase associated proteins |
| 09/14/2000 | WO2000031132A8 Novel polypeptide |
| 09/14/2000 | WO2000031074A3 Indole derivatives and their use as serotonin receptor ligands |
| 09/14/2000 | WO2000024717A3 Isoquinoline derivatives |
| 09/14/2000 | WO1999063999A8 H1-histamine receptor antagonists |
| 09/14/2000 | WO1999033836A9 3'-epimeric k-252a derivatives |
| 09/14/2000 | DE19911039A1 Abgewandelte Aminosäureamide, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung Modified amino acid amides, pharmaceutical compositions containing them and methods for their preparation |
| 09/14/2000 | DE19910370A1 Verfahren zur Herstellung von Tensidalkoholen und Tensidalkoholethern, die hergestellten Produkte und ihre Verwendung A process for the preparation of surfactant alcohols and surfactant alcohol ethers, the manufactured products and their use |